The body's delicate balancing act with a reactive metal
In short: Iron is a biological paradox. It is indispensable for life, powering everything from oxygen transport to DNA metabolism. Yet, in its raw form, it is highly reactive and capable of destroying cells. To survive, your body must master a complex regulatory system to keep this metal in check.
The human body relies on iron for several fundamental processes, including DNA biosynthesis, cellular energy generation, and the transport of oxygen. Because it is used by almost all organisms, it is a cornerstone of development and survival. It serves as a vital component of various enzymes. These enzymes facilitate numerous biological processes across different organisms.
Iron exists in two primary oxidative states: ferric (III) and ferrous (II). Ferric iron is stable but poorly soluble in water, while ferrous iron is water-soluble but highly reactive. To prevent damage, the body binds ferric iron to proteins like transferrin, which keeps the metal in a redox-inactive state for safe transport. This binding strategy ensures that the metal remains bioavailable. It allows the body to overcome the inherent solubility issues of ferric iron.
The danger of iron lies in its potential to create reactive oxygen species (ROS) through the Fenton reaction. When iron is in excess, this process causes cell death and organ failure, specifically targeting the liver, heart, pancreas, thyroid, and central nervous system. This risk is heightened because there is no physiological way to excrete iron, except through blood loss or the shedding of cells. The lack of a dedicated excretion pathway makes regulation critical. This makes the balance between utility and toxicity extremely fragile.
To manage this, the body uses a sophisticated regulatory network involving proteins such as ferritin for storage, transferrin for transport, and hepcidin for regulation. When this metabolism becomes deregulated, it can lead to severe pathologies, ranging from iron-deficiency anemia to iron-overload diseases like hereditary hemochromatosis. Researchers are currently exploring pharmacotherapies that target these key players to treat various diseases, including cancer and inflammation. Clinical research now focuses on these metabolic pathways. These efforts aim to address conditions like inflammation and various cancers.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Iron Physiology
- Also: Iron metabolism: Pathophysiology and Pharmacology
To cite this card, link to https://intellectplus.co.uk/app/science-iron-physiology.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Biochemistry · More in Science · Latest · A–Z · All topics